HDAC9 and Huntington disease: With respect to adverse side-effects of broad-spectrum HDAC inhibitors, the development of novel HDAC inhibitors with improved selectivity, potency, safety, and brain penetration will greatly advance the therapeutic potential HDAC inhibitors for chronic administration in diseases like HD.